CARDIAWAVE Revenue and Competitors

Paris, France

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • CARDIAWAVE's estimated annual revenue is currently $10.8M per year.(i)
  • CARDIAWAVE's estimated revenue per employee is $251,000

Employee Data

  • CARDIAWAVE has 43 Employees.(i)
  • CARDIAWAVE grew their employee count by 10% last year.

CARDIAWAVE's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$31.6M1269%N/AN/A
#2
$65.8M2623%N/AN/A
#3
$55.7M22247%N/AN/A
#4
$43.4M173-9%N/AN/A
#5
$32.4M1295%N/AN/A
#6
$115M4589%N/AN/A
#7
$36.4M1459%N/AN/A
#8
$143.7M409-11%€83.1MN/A
#9
$32.4M1292%N/AN/A
#10
$2571.2M102444%N/AN/A
Add Company

What Is CARDIAWAVE?

Innovation prize winner of many contests, Cardiawave is a clinical-stage company which develops an innovative non-invasive image-guided medical device (MD) to treat aortic valve stenosis with ultrasound technology. Aortic stenosis is a life-threatening disease which is a major public health concern in Western countries (10 million people affected). The MD uses focused ultrasound therapy to soften aortic valve leaflets and improve valve opening. The company was created at the end of 2014 as a result of a long-term partnership between the Langevin Institute / Physics for Medicine Paris, a world leader in ultrasound imaging and therapy, and the Georges Pompidou European Hospital (HEGP), a leader in the field of valve disease and cardiac ultrasound imaging.

keywords:N/A

N/A

Total Funding

43

Number of Employees

$10.8M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CARDIAWAVE News

2022-03-22 - Cardiawave Announces the Success of Its Clinical Trial to ...

Cardiawave has developed a non-invasive medical device VALVOSOFT® for the treatment of valvular heart diseases, and in particular, Aortic...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.1M43-4%N/A
#2
$4.1M43-20%N/A
#3
$11.2M43N/AN/A
#4
$4.5M4310%N/A
#5
$5M435%N/A